Hepatitis A Outbreak Among Injection Drug Users Along the Texas Mexico Border



Similar documents
Hepatitis C Infections in Oregon September 2014

THE A, B, C S OF HEPATITIS. Matt Eidem, M.D. Digestive Health Associates of Texas 1600 Coit Road Suite #301 Plano, Texas (972)

Viral Hepatitis A, B, and C

The Epidemiology of Hepatitis A, B, and C

Drug Use and Abuse in San Diego County, California: 2013

Testimony of. Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment

Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results

Drug Abuse Trends in the Seattle-King County Area: 2014

Drug Abuse Trends Minneapolis/St. Paul, Minnesota

HEPATITIS WEB STUDY Acute Hepatitis C Virus Infection: Epidemiology, Clinical Features, and Diagnosis

EPIDEMIOLOGY OF HEPATITIS B IN IRELAND

Epidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid

New York State Department of Health Immunization Program Combined Hepatitis A and B Vaccine Dosing Schedule Policy

Hepatitis Services in Substance Abuse Treatment Settings

english facts about hepatitis A, B and C

William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016

Guidelines for Viral Hepatitis CTR Services

1. Youth Drug Use More than 40% of Maryland high school seniors used an illicit drug in the past year.

Poor access to HCV treatment is undermining Universal Access A briefing note to the UNITAID Board

Drug Abuse Trends in the Seattle/King County Area: 2013

Strengthening the HCV Continuum of Care

Ebola: Teaching Points for Nurse Educators

Chapter 1 Overview of Tuberculosis Epidemiology in the United States

Case Finding for Hepatitis B and Hepatitis C

Sexual Health and Sexually Transmitted Infections Prevention and Control Protocol, 2013 (Revised)

Targeted HIV Testing & Enhanced Testing Technologies. HIV Prevention Section Bureau of HIV/AIDS

Disegion and the Hepatitis B HPV Vaccine - A Comparison

1.How did I get Hepatitis C?

Hepatitis A. Lori Fantry, MD, MPH

2. PROVISION OF COMBINED HEPATITIS A AND B VACCINE OR MONOVALENT HEPATITIS A OR HEPATITIS B VACCINE FOR HIGH RISK GROUPS

COMMUNICABLE DISEASE

Naloxone Distribution for Opioid Overdose Prevention

Drug Abuse Patterns and Trends in the San Francisco Bay Area Update: June 2014

California Adult Viral Hepatitis Prevention. Strategic Plan,

Drug Situation in Vancouver UHRI. Report prepared by the Urban Health Research Initiative of the British Columbia Centre for Excellence in HIV/AIDS

West Virginia HIV/AIDS Surveillance Report 2009 Update West Virginia HIV/AIDS Program

Hepatitis C Virus Infection in Massachusetts: A tale of two epidemics

Viral Hepatitis Case Report

Patterns and Trends of Drug Abuse in the Baltimore/Maryland/Washington, DC, Metropolitan Area Epidemiology and Trends:

3/25/2014. April 3, Dennison MM, et al. Ann Intern Med. 2014;160:

Managing Bloodborne Pathogens Exposures

When an occupational exposure occurs, the source patient should be evaluated for both hepatitis B and hepatitis C. (AII)

Drug Abuse Trends in the Seattle/King County Area: 2013

THIS IS AN OFFICIAL NH DHHS HEALTH ALERT

Integrating Viral Hepatitis Counseling and testing in Substance Abuse Programs. By Barbara Rush CAAPP2 The Center For Drug Free Living Inc.

Hepatitis C. Screening, Diagnosis and Linkage to Care

Hospitalizations for Hepatitis A, B, and C, Active Component, U.S. Armed Forces,

GUIDELINES FOR THE MANAGEMENT OF HEPATITIS C

Bloodborne Pathogens. San Diego Unified School District Nursing & Wellness Program August 2013

Commonly Asked Questions About Chronic Hepatitis C

Appendix 3 Exposure Incident Report Form

Substance Abuse Treatment Evaluations and Interventions Program

Placing Nation on the Path Toward the Elimination of Hepatitis C

Using HIV Surveillance Data to Calculate Measures for the Continuum of HIV Care

Dallas National HIV Behavioral Surveillance System 2009 Annual Data Report Injection Drug Use

GUIDELINES FOR VIRAL HEPATITIS SURVEILLANCE AND CASE MANAGEMENT

The NJSAMS Report. Heroin Admissions to Substance Abuse Treatment in New Jersey. In Brief. New Jersey Substance Abuse Monitoring System.

Using Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services

Understanding Hepatitis C:

Meningococcal Disease Among Men Who Have Sex with Men United States, January June 2015

Guidelines for Managing Exposures to Blood Borne Pathogens

AN OVERVIEW OF PROGRAMS FOR PEOPLE WHO INJECT DRUGS

OUTLINE POST EXPOSURE PROPHYLAXIS (PEP) OCCUPATIONAL RISK OF VIRAL TRANSMISSION WITH SHARP INJURY FROM INFECTED SOURCE:

EXECUTIVE SUMMARY: INTEGRATED EPIDEMIOLOGIC PROFILE FOR HIV/AIDS PREVENTION AND CARE ELIGIBLE METROPOLITAN AREA PLANNING, PHILADELPHIA

Hepatitis C. Eliot Godofsky, MD University Hepatitis Center Bradenton, FL

Prison and Jail Health January 18, Viewer Call-In. Evaluations. Phone: Fax:

Strategies to Improve the HCV Continuum of Care:

September 17, Dear Secretary Sebelius:

Methamphetamine in Oregon

HIV Infection Among Those with an Injection Drug Use*-Associated Risk, Florida, 2014

Chapter 20: Analysis of Surveillance Data

EMERGING CLINICAL ISSUE: HEPATITIS C INFECTION IN HIV-INFECTED MEN WHO HAVE SEX WITH MEN

Bloodborne Pathogens (HIV, HBV, and HCV) Exposure Management

HD Journal of Health Disparities Research and Practice Volume 5, Number 1, Summer 2011, pp

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Integrating Hepatitis, STD, and HIV Services into a Drug Rehabilitation Program

Jennifer Sharpe Potter, PhD, MPH Associate Professor Division of Alcohol and Drug Addiction Department of Psychiatry

County of Los Angeles Adult Viral Hepatitis Prevention Plan

Body Fluid Exposure:

Rural Substance Abuse Partnership (RSAP) State Profile: OKLAHOMA

Patient Information Sheet

Trends in Human Immunodeficiency Virus Infection among Drug Users in a Detoxification Unit

Evidence based Prevention & Treatment Options for Emerging Heroin Use in a Public Health Framework

UCSF Communicable Disease Surveillance and Vaccination Policy

A Ministry of the Archdiocese of Galveston-Houston A United Way Agency

Statistics on Women in the Justice System. January, 2014

Are you Hep C aware? awareness information support prevention To find out more visit

Estimates of New HIV Infections in the United States

Hepatitis C Virus Infection: Prevalence Report, 2003 Data Source: Minnesota Department of Health HCV Surveillance System

Kean University BS Degree Program in Athletic Training BLOOD BORN PATHOGENS POLICY

Hepatitis A. Case Investigation and Public Health Response

Immunization Safety Office. Updates

Hepatitis A/B Vaccination of inmates in the Los Angeles County Jail

Viral hepatitis. Report by the Secretariat

Medical Conditions and Health Care in Prisons

Stimulants Notes. What is heroin?

PREPARED BY THE CENTER FOR HEALTH LAW AND POLICY INNOVATION OF HARVARD LAW SCHOOL

Kathryn P. Jett Director

Bloodborne Pathogens (BBPs) Louisiana Delta Community College

PLUS MAY EQUAL. Flu-Like Symptoms SORE THROAT, SWOLLEN GLANDS, FEVER, JOINT AND MUSCLE ACHES

Transcription:

Hepatitis A Outbreak Among Injection Drug Users Along the Texas Mexico Border National Viral Hepatitis Prevention Conference Washington DC Dec. 5 9, 2005 Gary Heseltine MD MPH Epidemiologist Infectious Disease Control Unit Texas Department of State Health Services

The Mix Drugs Sex and sex workers Marginalized individuals Predominantly males Bustling cross border environment Hepatitis A virus Hepatitis C virus (Human Immunodeficiency virus?) Public health department

Hepatitis A is of low endemicity in the United States and high endemicity in Mexico From CDC slide set

Risk Groups for Hepatitis A Unknown 46% Sexual or Household Contact 14% International travel 5% Men who have sex with men 10% Injection drug use 6% Other Contact 8% Contact of daycare child/employee 6% Food- or waterborne outbreak 4% Child/employee in day-care 2% Risk Factors Associated with Reported Hepatitis A, 1990-2000, United States From CDC slide set

Concentration of Hepatitis A Virus in Various Body Fluids Feces Body Fluids Serum Saliva Urine 10 0 10 2 10 4 10 6 10 8 10 10 Infectious Doses per ml Source: Viral Hepatitis and Liver Disease 1984;9-22 J Infect Dis 1989;160:887-890 Figure from CDC hepatitis A slide set

Hepatitis A in Drug Users Hepatitis A outbreaks among drug users have been reported from many places, including Europe, many US states, and Australia (Shaw 1997-98; Delpech et al 2000). Drugs associated with outbreaks include IV amphetamines such as methamphetamine, heroin, IV cocaine, and smoked marijuana (CDC 1988; Vong et al 2005).

HCV HAV Superinfection Vento et al, Jan 29, 1998 NEJM Prospective study 86 months, 432 patients HCV+ All were seronegative for HAV at start 17 contracted HAV infection Fulminating hepatic failure in 7, 6 deaths None of the 7 had cirrhosis, 3 had HGV Remaining 10 had uncomplicated course 35% case fatality with HAV superinfection Autoimmune mechanism postulated Drop in HCV viral levels during infection

Webb County, Texas In south Texas, bordering the states of Nuevo León and Coahuila, Mexico

Hepatitis A in Webb County, Texas 200 180 160 Vaccine licensed in USA, 1995 Texas border vaccine requirement, 1999 140 120 100 80 60 40 20 0 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 Year Number of cases

2003- Webb, Dimmit, Starr, and Hidalgo Counties 2004- Webb County In 2003, hepatitis A cases occurred throughout the year. In 2004, most patients with lab-confirmed hepatitis A had an onset of symptoms during the last three months of the year

2003- Webb, Dimmit, Starr, and Hidalgo Counties 2004- Webb County In 2004, there was a higher percentage of males among the hepatitis A confirmed cases. This pattern is common during drug-related outbreaks.

2003- Webb, Dimmit, Starr, and Hidalgo Counties 2004- Webb County In 2004, there was a greater concentration of young adults among the laboratory confirmed hepatitis A cases. This pattern is common during drug-related outbreaks.

Risk factors associated with outbreak, October 2004 January 2005, n = 27 Risk Factor n (%) ------------------------------------------------------------------- Male 21 (78%) Hepatitis C co-infection 10 (37%) IV drug use 16 (59%) Non-IV drug use 6 (22%) IV and/or non-iv drug use 19 (70%) Drug use or close contact of user 20 (74%) Homeless or marginally homeless 4 (15%) Drug association and/or homeless 21 (78%)

Profile of the 20 drug-associated cases 75% were male Median age 28.5 years (range 21-52 years) 9 were reported to use cocaine and 5 had a reported connection to heroin. Of these, 2 were reported to use both cocaine and heroin. 11 had stayed at or visited a particular hotel, where drugs and sex were shared

Drug Use Associated with Hepatitis A Webb County IV Drug 3 Use No Drug Use Unknown 2 Count 1 0 11/13/2004 11/6/2004 10/30/2004 10/23/2004 10/16/2004 10/9/2004 10/2/2004 9/25/2004 9/18/2004 9/11/2004 12/25/2004 12/18/2004 12/11/2004 12/4/2004 11/27/2004 11/20/2004 OnSet_Date

Drug Associated Cases Hotel C Link Onset 11/06/04 Cocaine & Heroin IV Drug User Shared IV Drugs Onset 10/31/04 Cocaine IV Drug User Shared IV Drugs Shared IV Drugs Acquaintance Onset 10/10/04 Cocaine & Heroin IV Drug User Homeless Acquaintance Sexual & IV Drug Use Onset 10/15/04 Cocaine IV Drug User Homeless Prostitute Shared IV Drugs Shared IV Drugs Onset 11/30/04 Cocaine IV Drug User Shared IV Drugs Shared IV Drugs Acquaintance Onset 12/05/04 Cocaine IV Drug User Acquaintance Onset 11/25/04 Cocaine Non-IV Drug User Acquaintance Onset 11/27/04 IV Drug User Onset 11/04/04 IV Drug User Homeless Acquaintance Onset 11/24/04 IV Drug User Legend Frequented Hotel C Females Males

Drug Associated Cases Hepatitis C Co-infection Onset 11/06/04 Cocaine & Heroin IV Drug User Shared IV Drugs Onset 10/31/04 Cocaine IV Drug User Shared IV Drugs Shared IV Drugs Acquaintance Onset 10/10/04 Cocaine & Heroin IV Drug User Homeless Acquaintance Sexual & IV Drug Use Onset 10/15/04 Cocaine IV Drug User Homeless Prostitute Shared IV Drugs Shared IV Drugs Onset 11/30/04 Cocaine IV Drug User Shared IV Drugs Shared IV Drugs Acquaintance Onset 12/05/04 Cocaine IV Drug User Acquaintance Onset 11/25/04 Cocaine Non-IV Drug User Acquaintance Onset 11/27/04 IV Drug User Onset 11/04/04 IV Drug User Homeless Acquaintance Onset 11/24/04 IV Drug User Legend Hepatitis C Females Males

Interventions to contain the cluster Case investigations and contact tracing Immune globulin to close contacts who were identified in time for the IG to be effective Outreach to homeless and IDU populations Information on disease shared Hygiene education provided Immunizations provided to high-risk adults: 14 for hepatitis A and 23 for hepatitis B Outreach to medical providers to be on alert for the possibility of hepatitis A in IDU or homeless patients

Special Thanks To: Allison J. Abell, PhD 1 Waldo Lopez, MPH 2 Linda K. Gaul, PhD, MPH 3 Elida Torres 1 1 Texas Department of State Health Services, Health Services Region 11, Harlingen 2 City of Laredo Health Department 3 Texas Department of State Health Services, Austin

Acknowledgements The following persons provided valuable assistance with various phases of the investigation: Brian Smith, MD, MPH Hector Gonzalez, MD, MPH Melissa Davis, RN, MS Margarita Davidson Maria Maldonado, MA, SWA, MT, AMT Blanca Gonzalez, RN Veronica Vierra, RN, BSN Tom Betz, MD, MPH Maggie Hernandez, LVN

Literature cited Centers for Disease Control and Prevention. 1988. Hepatitis A among drug abusers. MMWR Morb Mort Wkly Rep 37(19): 297-300, 305. Delpech VC, Thackway SV, Young L, Pontivivo G, Smedley E, Morgan K, and Ferson MJ. 2000. Hepatitis A in south-eastern Sydney 1997-1999: continuing concerns for gay men and an outbreak among illicit drug users. Comm Dis Intell 24: 203-206. Drug pictures from http://www.drugs.indiana.edu/graphics/photographs Shaw, Frederic E. 1997-98. Drug-linked HAV outbreaks tax health departments. Hepatitis Control Report, Vol 2, No 4. http://www.hepatitiscontrolreport.com/v2n4.html Vong S, Fiore AE, Haight DO, Li J Borgsmiller N, Kuhnert W, Pinero F, Boaz K, Badsgard T, Mancini C, Nainan OV, Wiersma S, Bell BP. 2005. Vaccination in the county jail as a strategy to reach high risk adults during a community-based hepatitis A outbreak among methamphetamine users. Vaccine 23: 1021-1028.

Summary In Texas, the incidence of hepatitis A declined from about 16 per 100,000 population in the mid-1990s to just under 3 per 100,000 in 2003. The median age of a case in 1995 was 17 years, while in 2003 it was 38 years. Mandatory vaccination for school attendance began in1999 with 32 counties and expanded to cover 41 counties by 2004. The targeted counties had the highest hepatitis A incidence rates and included the 14 counties along the Texas-Mexico border. Between mid-october 2004 and mid-january 2005, a cluster of 27 laboratoryconfirmed cases of hepatitis A was recorded in Webb County. Investigations revealed that 19 of the 27 cases had a history of injecting and/or noninjecting drug use during the 2-6 weeks preceding symptom onset; an additional case patient had an association with a drug user. Two of the drug-related case patients had a recent history of cross-border travel. Four of the drug-using case patients were homeless and at least 11 frequented a hotel/abandoned building where sex and drugs were shared. The median age of the drug-related cases was 28.5 years and 75% were males. About two-thirds cases were hospitalized. At least nine of the 20 drug-related case patients also had hepatitis C infection. None of the co-infected cases died. The local health department administered immune globulin to close contacts of case patients as appropriate. Additionally, hepatitis A and B vaccine was administered to members of this cluster with the hepatitis A vaccine being more broadly offered to all identified homeless persons, injection drug users, and prostitutes within the city during this period.

Injecting Drug Use and HCV Highly efficient Transmission Contamination of drug paraphernalia, not just needles and syringes Rapidly acquired after initiation Incidence 15% per year Prevalence 30% after 2-3 years; >50% after 5 years Four times more common than HIV

Risk of HCV Infection Among Injection Drug Users Seroprevalence (%) 100 80 60 40 20 0 Baltimore: 1983-1988 NY - Harlem: 1997-99 NY LES: 1997-99 Chicago: 1997-99 0 6 12 18 24 30 36 42 48 54 60 66 72 78 84 Duration of Injection (months) Garfein RS Am J Public Health 1996; 86:655. Thorpe LE JID 2000;182:1588-94. Diaz T Am J Public Health 2001; 91(1): 23-30.

TDSHS-Fu nded Treatment with a Primary Problem with Heroin by Route of Administration: Jan-June 2004 Inject Inhale Smoke AII* # Admissions 2,394 255 27 2,702 of Heroin Admits 89 9 1 100 ag-1st Use to Tmt-Yrs_ 16 8 7 15 Male 37 69 29 53 28 48 36 67 Black 6 33 7 9 White 37 18 44 35 Hispanic CJ Involved 55 31 47 29 41 15 54 30 Employed Homeless 11 13 16 10 7 7 12 13 Average Age...Total includes clients with other routes of administration.

Exhibit 17. Characteristics ofclients Admitted to TDSHS-Funded Treatment with a Primary Problem of Amphetamines or Methamphetamines by Route ofadministration: First Half 2004 # Admissions Smoke 911 Inject 1,292 Inhale 299 Oral 103 AII* 2,607 % of Stimulant Admits 35 50 12 4 100 Lag-1st Use to Tmt-Yrs. Average Age-Yrs. % Male 9 28 44 13 31 47 10 31 48 11 31 48 11 30 46 % Black 1 0 1 2 1 % White 86 95 87 84 90 % Hispanic % CJ Involved 10 48 4 51 9 48 13 52 7 50 % Employed % Homeless 22 7 16 10 25 6 26 11 19 9 'Total includes clients with "other" routes of administration

Exhibit 10. Heroin Admissions to TCADA-Funded Treatment by Race/Eth nicily: 1986-First Half 2004 100 % 86 87 88 89 90 91 92 93 94 95 96 97 98 99 00 01 02 03 04 ource: TDSHS Black 0 White 0 Hispanic